Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sinopharm Group Co's Enterprise Value is $16,613 Mil.
Sinopharm Group Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $2,303 Mil. Therefore, Sinopharm Group Co's EV-to-EBIT ratio for today is 7.21.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Sinopharm Group Co's Enterprise Value is $16,613 Mil.
Sinopharm Group Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was $2,623 Mil. Therefore, Sinopharm Group Co's EV-to-EBITDA ratio for today is 6.33.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Sinopharm Group Co's Enterprise Value is $16,613 Mil.
Sinopharm Group Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was $80,427 Mil. Therefore, Sinopharm Group Co's EV-to-Revenue ratio for today is 0.21.
Sinopharm Group Co Enterprise Value Historical Data
The historical data trend for Sinopharm Group Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sinopharm Group Co's Enterprise Value
For the Medical Distribution subindustry, Sinopharm Group Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopharm Group Co's Enterprise Value Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Sinopharm Group Co's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Sinopharm Group Co's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Group Co (OTCPK:SHTDF) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Sinopharm Group Co's current Enterprise Value is $16,613 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sinopharm Group Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $2,303 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Sinopharm Group Co's current Enterprise Value is $16,613 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sinopharm Group Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was $2,623 Mil.
Sinopharm Group Co's current Enterprise Value is $16,613 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sinopharm Group Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was $80,427 Mil.
Sinopharm Group Co's current Enterprise Value is $16,613 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sinopharm Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was $2,437 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Group Co Enterprise Value Related Terms
Thank you for viewing the detailed overview of Sinopharm Group Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHTDF has been successfully added to your 